Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Pressemeddelelse

Conference call on Interim Report

Xvivo Perfusion

Invitation to attend XVIVO’s conference call regarding the presentation of the interim report January-September 2024. The presentation will be held in English.

Time: Thursday, October 24 at 2.00 pm CET / 8.00 am EST

If you wish to participate via webcast please use the link below. Via the webcast you are able to ask written questions. https://ir.financialhearings.com/xvivo-q3-report-2024

If you wish to participate via teleconference please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. Via the teleconference you can ask questions verbally.
https://conference.financialhearings.com/teleconference/?id=50046879
 
Participants from XVIVO:
Christoffer Rosenblad, CEO
Kristoffer Nordström, CFO
 
The press release for XVIVO’s interim report January-September 2024 will be released on October 24, 2024 at 7.30 am CET / 1.30 am EST.
 
Before the conference call, slides will be available at the company web page, https://www.xvivogroup.com/investors/reports-and-presentations/

Oktober 10, 2024
Mölndal
XVIVO Perfusion AB (publ)

For further information, please contact:


Christoffer Rosenblad, CEO, +46 73 519 21 59, e-mail: christoffer.rosenblad@xvivogroup.com
Kristoffer Nordström, CFO, +46 73 519 21 64, e-mail: kristoffer.nordstrom@xvivogroup.com

About Us


Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs - so transplant teams around the world can save more lives. Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine. XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on two continents. The company is listed on Nasdaq Stockholm under the ticker symbol XVIVO. More information can be found on the website www.xvivogroup.com.

Attachments


Conference call on Interim Report

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team